National Activation

Approximately 75% of the 4.3 million premature cancer deaths worldwide each year occur in LMICs. By 2030, it is estimated that 70% of all global cancer deaths will be in LMICs. We are calling on you to help us make a difference.

Express your interest in Treatment for All

At the 2018 World Cancer Leaders’ Summit held on 1st October in Kuala Lumpur, Malaysia, UICC launched a call for expressions of interest to become a ‘Treatment for All’ Country Champion or Mentor. Through national activation of ‘Treatment for All’, UICC members can play an active role in advocating for national implementation of global cancer commitments. The call for Country Champions closed Friday, 30 November, but the call for Mentors remains open.

About National activation

National Activation of the global UICC Treatment for All advocacy campaign is specifically focused on working with and supporting UICC members, partners and its network to mobilise and equip civil society at national level with the skills to identify advocacy priorities. In line with Treatment for All, we will work meaningfully across civil society and with government to translate global cancer commitments into effective national action, thereby improving patient outcomes. Together, UICC and member organisations will identify key strengths and gaps in their country’s health system, and define areas of support needed to deliver a strong civil society advocacy campaign on Treatment for All.

By focusing our attention on LMICs, we have the opportunity to create long-term, sustainable solutions in those parts of the world where we anticipate the greatest burden and to contribute meaningfully to the delivery of the NCD and SDG global targets to reduce premature deaths caused by cancer and the other NCDs, as well as on the commitments agreed in the cancer resolution.

TFA mortality 9.6.png


No matter where each country stands, or which inequities each country faces, Treatment for All captures the importance of addressing all cancers at all stages, for all ages, in all contexts in order to improve patient outcomes with cost-effective, timely and quality treatment and care, and without bias.

Our vision is that, in 2025, when the United Nations measures progress against NCD targets agreed by Member States as part of the 2011 Declaration on NCDs, the cancer community will be proud to report that their collective action has not only helped prioritise cancer control and shape adequate national policies, but also laid a solid foundation for sustainable growth, in line with the ambitions of the 2030 Agenda for Sustainable Development.

In 2018, three countries embarked on the journey to develop and implement their national Treatment for All advocacy campaigns: Uganda Cancer Society, Uganda; Salvati A.C., Mexico; and Indonesian Cancer Foundation, Indonesia.

Engage online


For insights into their experiences so far and the value of the campaign from the perspective of their national context, please take a look at the UICC blog for recent articles from Adela Ayensa Alonso, General Director of Salvati A.C,  Paul Ebusu, Executive Director of Uganda Cancer Society, and Professor Aru Sudoyo, Chair of Indonesian Cancer Foundation

In the news

Treatment for All focal points representing civil society organisations from Indonesia, Mexico and Uganda joined UICC staff in Geneva, Switzerland for shared learning and shared representation at the World Health Assembly (WHA) as part of joint preliminary efforts to translate global commitments into national action. Read more here.

On May 29th, 2018, more than 300 medical personnel showed up to the Kaohsiung Chang Gung Memorial Hospital, Taiwan in a flash mob calling for Treatment for All. Read more here.

Social media

All members and the extended cancer community are encouraged to get involved and support the campaign efforts through use of the social media toolkit and by contacting us to share their related activities.

Treatment for All - Howe to get involved


to discover best practices and success stories


Last update: 
Monday 11 February 2019